Poveda, Alaitz
Pomares-Millan, Hugo
Chen, Yan
Kurbasic, Azra
Patel, Chirag J.
Renström, Frida
Hallmans, Göran
Johansson, Ingegerd
Franks, Paul W.
Funding for this research was provided by:
Innovative Medicines Initiative of the European Union (no. 875534 – SOPHIA)
H2020 European Research Council (2015_681742_NASCENT)
Swedish Research Council, Strategic Research Area Exodiab (Dnr 2009-1039)
Swedish Foundation for Strategic Research (IRC15-0067)
Swedish Research Council, Linnaeus Grant (Dnr 349-2006-237)
Lund University
Article History
Received: 25 March 2021
Accepted: 28 February 2022
First Online: 8 March 2022
Competing interests
: The authors declare no competing interests.